findmyKOL

Ayalew Tefferi, MD

Enriched profile

Professor of Medicine (Hematology), Consultant in Hematology · Mayo Clinic

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Rochester, MN · Midwest · United StatesSpecialtyHematologyFocusMyeloproliferative Neoplasms: Diagnosis and Treatment+4
Active KOLfindmyKOL type: RegionalLatest publication2026Online presenceverified 2026PaymentsNone reportedNIH funding1993–1999Why? →

Ayalew Tefferi is Professor of Medicine (Hematology), Consultant in Hematology at Mayo Clinic. OpenAlex indexes 2,093 publications with 104,476 citations (h-index 154); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Hematology profiles in the findmyKOL directory. Clarivate lists Ayalew Tefferi as a Highly Cited Researcher (Clinical Medicine, 2014, 2016-2021).

Data verified 17 Oct 2026

Overview

Updated 17 Oct 2026

Ayalew Tefferi, M.D., is Professor of Medicine (Hematology), Consultant in Hematology at Mayo Clinic, Rochester, Minnesota (Mayo Clinic College of Medicine and Science, Division of Hematology, Department of Medicine). The public record shows 2,093 publications with 104,476 citations (h-index 154), centered on Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments. It also documents an investigator role on 7 registered clinical trials, 1 NIH-funded awards (1993–1999).

  • Most recent indexed publication: 2026 · American journal of hematology
  • Top research focus: Myeloproliferative Neoplasms: Diagnosis and Treatment
  • 7 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 17 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
MDS / MPN7 trialsPrimary Myelofibrosis7 trialsPolycythemia Vera4 trialsThrombocytosis4 trialsPolycythemia4 trialsThrombocythemia, Essential3 trialsMyeloproliferative Disorders1 trialLeukemia (AML/ALL/CML/CLL)

Research focus

OpenAlex concept fingerprint
Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsEosinophilic Disorders and SyndromesKruppel-like factors research

Drugs & molecules

across trials, industry payments and publications
MomelotinibClinical trials2Industry payments—Publications10FedratinibClinical trials2Industry payments—Publications3RuxolitinibClinical trials1Industry payments—Publications3LenalidomideClinical trials1Industry payments—Publications2PomalidomideClinical trials1Industry payments—Publications—PrednisoneClinical trials1Industry payments—Publications—

Works with

trial sponsors and companies reporting payments
Sierra Oncology LLC - a GSK companyClinical trials2Industry payments—Bristol-Myers SquibbClinical trials1Industry payments—Incyte CorporationClinical trials1Industry payments—Mayo ClinicClinical trials1Industry payments—National Cancer Institute (NCI)Clinical trials1Industry payments—TargeGenClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
2,093publications

Distinct works indexed by OpenAlex, matched via ORCID; 239 in PubMed.

104,476citations

Total citations across indexed works.

154h-index

Hirsch index (OpenAlex). i10-index 1,018.

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials ↓
0companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 1993–1999

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 17 Oct 2026

Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:

All 7 trial records: search, sort and filter.Explore →

Industry payments

No payments involving this person were reported to CMS in program years 2021–2024. Why? →

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    94.2%
    SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor69.3%
    Remdesivir100%
    Part B, office-administered≥17 patients
    Human Immunoglobulin G24.9%
    Immune globulin100%
    Part B, office-administered≥12 patients

  • Cancer & immunology

    5%
    Janus-associated kinase (JAK) inhibitors2.3%
    Ojjaara100%
    Part D≥12 patients
    Antimetabolite1.3%
    Hydroxyurea100%
    Part D≥13 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    0.4%
    Corticosteroid0.4%
    Prednisone100%
    Part D<11 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 17 Oct 2026

1 NIH research award on record, funded 1993–1999 per NIH RePORTER. The latest:

Publications

Updated 17 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 239 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
    4,417 citations2009
    doi.org ↗
  2. 02
    Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
    2,991 citations2005
    doi.org ↗
  3. 03
    International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
    2,704 citations2022
    doi.org ↗
  4. 04
    A Tyrosine Kinase Created by Fusion of the <i>PDGFRA</i> and <i>FIP1L1</i> Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome
    1,698 citations2003
    doi.org ↗
  5. 05
    New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
    1,239 citations2008
    doi.org ↗
All 2,093 cited works: search, sort and filter.Explore →

Network

Updated 17 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Animesh Pardanani692Naseema Gangat615Terra L. Lasho435Mrinal M. Patnaik420Curtis A. Hanson330Christy M. Finke297Aref Al‐Kali280Rhett P. Ketterling278Mark R. Litzow236Kebede H. Begna203Ruben A. Mesa196Abhishek A. Mangaonkar189William J. Hogan187Robert F. Groff184Günter Burg184Urban W. Geisthoff184Amaj Ikomi184Stefan R. Bornstein184Konrad Sandhoff184Shah Azmoon184Nitin Wadhani184Karina Yazdanbakhsh184Claudio Guarneri184Jacky Bonaventure184Nenad Blau184Han‐Mou Tsai184Elizabeth Goldmuntz184Jason H. Huang184Julian Ilcheff184Nicholas J. Sarlis184Jürgen Kohlhase184Gregory Y.H. Lip184Ingo B. Autenrieth184Werner Kempf184Bob Olsson184Genovefa Kolovou184John‐John B. Schnog184Bharat K. Kantharia184Peter Kopp184Roel de Weger184

Online presence

Updated 17 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Facebook

    facebook.com/ayalew.tefferi

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗

Mentions by others

where others cite or feature them
  • Doximity

    doximity.com/pub/ayalew-tefferi-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/posts/jamanetwork_author-ayalew-tefferi-of-the-mayo-clinic-activity-7289960451625435136-oYgz

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • Other

    bloodcancerstoday.com/podcast/ayalew-tefferi-md-on-risk-stratification-treatment-considerations-for-myelofibrosis

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bloodcancerstoday.com ↗
  • Other

    hemehub.org/event-details/essential-thrombocytosis-with-dr-ayalew-tefferi-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hemehub.org ↗
  • Other

    hemehub.org/event-details/jak2-negative-erythrocytosis-with-dr-ayalew-tefferi-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hemehub.org ↗
  • ResearchGate

    researchgate.net/lab/Ayalew-Tefferi-Lab

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Ayalew-Tefferi-39646254

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • Spotify

    open.spotify.com/episode/5b4icl8U9OouMk8QPsEUkY

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →open.spotify.com ↗
  • X / Twitter

    x.com/rajshekharucms/status/1644080529011273728

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 17 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Fellowship

    Hematology and Medical Oncology, Mayo Clinic College of Medicine and Science

    1989
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
  • Residency

    Internal Medicine, Ascension Illinois/Saint Joseph Chicago

    1986
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
  • M.D.

    University of Athens Medical School, Athens, Greece

    1981
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗
  • Board Certified

    American Board of Internal Medicine - Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com ↗
  • Board Certified

    American Board of Internal Medicine - Hematology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com ↗

Editorial & leadership roles

journal and society appointments
  • Editor-in-Chief

    Blood Cancer Journal (Nature Portfolio), alongside co-Editor-in-Chief Vincent Rajkumar

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • Associate/Section Editor

    American Journal of Hematology, Leukemia, European Journal of Hematology, Hematological Oncology, and Mayo Clinic Proceedings

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayo.edu ↗

Highly Cited Researcher

Clarivate's annual list, by award category and year
  • Clinical Medicine
    2014201620172018201920202021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Listed specialist/contributor

    Aplastic Anemia and MDS International Foundation (AAMDSIF) physician directory

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aamds.org ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.